HEADER OXIDOREDUCTASE 25-NOV-98 1B16 TITLE ALCOHOL DEHYDROGENASE FROM DROSOPHILA LEBANONENSIS TERNARY COMPLEX TITLE 2 WITH NAD-3-PENTANONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (ALCOHOL DEHYDROGENASE); COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.1.1.1; COMPND 5 OTHER_DETAILS: NAD-3-PENTANONE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCAPTODROSOPHILA LEBANONENSIS; SOURCE 3 ORGANISM_TAXID: 7225 KEYWDS OXIDOREDUCTASE, DETOXIFICATION, METABOLISM, ALCOHOL DEHYDROGENASE, KEYWDS 2 DROSOPHILA LEBANONENSIS, SHORT-CHAIN DEHYDROGENASES/REDUCTASES, KEYWDS 3 TERNARY COMPLEX, NAD-3- PENTANONE ADDUCT EXPDTA X-RAY DIFFRACTION AUTHOR J.BENACH,S.ATRIAN,R.GONZALEZ-DUARTE,R.LADENSTEIN REVDAT 3 13-JUL-11 1B16 1 VERSN REVDAT 2 24-FEB-09 1B16 1 VERSN REVDAT 1 29-NOV-99 1B16 0 JRNL AUTH J.BENACH,S.ATRIAN,R.GONZALEZ-DUARTE,R.LADENSTEIN JRNL TITL THE CATALYTIC REACTION AND INHIBITION MECHANISM OF JRNL TITL 2 DROSOPHILA ALCOHOL DEHYDROGENASE: OBSERVATION OF AN JRNL TITL 3 ENZYME-BOUND NAD-KETONE ADDUCT AT 1.4 A RESOLUTION BY X-RAY JRNL TITL 4 CRYSTALLOGRAPHY. JRNL REF J.MOL.BIOL. V. 289 335 1999 JRNL REFN ISSN 0022-2836 JRNL PMID 10366509 JRNL DOI 10.1006/JMBI.1999.2765 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.BENACH,S.ATRIAN,R.GONZALEZ-DUARTE,R.LADENSTEIN REMARK 1 TITL THE REFINED CRYSTAL STRUCTURE OF DROSOPHILA LEBANONENSIS REMARK 1 TITL 2 ALCOHOL DEHYDROGENASE AT 1.9 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 282 383 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 84601 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3926 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 485 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.150 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.170 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1B16 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-99. REMARK 100 THE RCSB ID CODE IS RCSB007202. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X31 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9511 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 103695 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.320 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR, AMORE, CCP4, O, MAIN, RAVE REMARK 200 STARTING MODEL: 1A4U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 28% PEG REMARK 280 2000, 0.2 M CACL2, 0.1 M TRIS-HCL, PH= 7.5, 1MM NAD+, 1% 3- REMARK 280 PENTANONE, 4 C. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.50000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 38 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ASP A 123 CB - CG - OD1 ANGL. DEV. = 6.1 DEGREES REMARK 500 PHE A 221 CB - CG - CD2 ANGL. DEV. = -4.3 DEGREES REMARK 500 PHE A 221 CB - CG - CD1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ASP A 237 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 12 47.28 71.01 REMARK 500 LYS A 83 -54.24 78.41 REMARK 500 ASP A 96 91.87 -171.53 REMARK 500 GLN A 99 76.27 -117.68 REMARK 500 PHE A 108 -65.67 -121.17 REMARK 500 CYS A 137 -114.35 -99.02 REMARK 500 SER A 138 147.97 172.24 REMARK 500 ALA B 12 46.06 76.35 REMARK 500 ASN B 29 42.21 73.64 REMARK 500 LYS B 83 -55.20 76.76 REMARK 500 ASP B 96 93.06 -171.79 REMARK 500 GLN B 99 76.57 -116.46 REMARK 500 CYS B 137 -114.80 -99.51 REMARK 500 SER B 138 148.48 175.29 REMARK 500 HIS B 253 -1.51 76.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 144 ILE A 145 147.63 REMARK 500 ALA B 144 ILE B 145 145.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ARG B 185 11.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 865 DISTANCE = 5.58 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 NAD-3-PENTANONE ADDUCT REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ACTIVE SITE, CATALYIC TRIAD. REMARK 800 REMARK 800 SITE_IDENTIFIER: NA1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NAD BINDING MOTIF IN DADHS G(A)XGXXG REMARK 800 REMARK 800 SITE_IDENTIFIER: NA2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NAD BINDING MOTIF IN SDRS GXXXGXG REMARK 800 REMARK 800 SITE_IDENTIFIER: NA3 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NAD/NADP SELECTIVITY AMINOACID REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ACTIVE SITE, CATALYIC TRIAD. REMARK 800 REMARK 800 SITE_IDENTIFIER: NA4 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NAD BINDING MOTIF IN DADHS G(A)XGXXG REMARK 800 REMARK 800 SITE_IDENTIFIER: NA5 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NAD BINDING MOTIF IN SDRS GXXXGXG REMARK 800 REMARK 800 SITE_IDENTIFIER: NA6 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: NAD/NADP SELECTIVITY AMINOACID REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAQ A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAQ B 500 DBREF 1B16 A 1 254 UNP P10807 ADH_DROLE 1 254 DBREF 1B16 B 1 254 UNP P10807 ADH_DROLE 1 254 SEQRES 1 A 254 MET ASP LEU THR ASN LYS ASN VAL ILE PHE VAL ALA ALA SEQRES 2 A 254 LEU GLY GLY ILE GLY LEU ASP THR SER ARG GLU LEU VAL SEQRES 3 A 254 LYS ARG ASN LEU LYS ASN PHE VAL ILE LEU ASP ARG VAL SEQRES 4 A 254 GLU ASN PRO THR ALA LEU ALA GLU LEU LYS ALA ILE ASN SEQRES 5 A 254 PRO LYS VAL ASN ILE THR PHE HIS THR TYR ASP VAL THR SEQRES 6 A 254 VAL PRO VAL ALA GLU SER LYS LYS LEU LEU LYS LYS ILE SEQRES 7 A 254 PHE ASP GLN LEU LYS THR VAL ASP ILE LEU ILE ASN GLY SEQRES 8 A 254 ALA GLY ILE LEU ASP ASP HIS GLN ILE GLU ARG THR ILE SEQRES 9 A 254 ALA ILE ASN PHE THR GLY LEU VAL ASN THR THR THR ALA SEQRES 10 A 254 ILE LEU ASP PHE TRP ASP LYS ARG LYS GLY GLY PRO GLY SEQRES 11 A 254 GLY ILE ILE ALA ASN ILE CYS SER VAL THR GLY PHE ASN SEQRES 12 A 254 ALA ILE HIS GLN VAL PRO VAL TYR SER ALA SER LYS ALA SEQRES 13 A 254 ALA VAL VAL SER PHE THR ASN SER LEU ALA LYS LEU ALA SEQRES 14 A 254 PRO ILE THR GLY VAL THR ALA TYR SER ILE ASN PRO GLY SEQRES 15 A 254 ILE THR ARG THR PRO LEU VAL HIS THR PHE ASN SER TRP SEQRES 16 A 254 LEU ASP VAL GLU PRO ARG VAL ALA GLU LEU LEU LEU SER SEQRES 17 A 254 HIS PRO THR GLN THR SER GLU GLN CYS GLY GLN ASN PHE SEQRES 18 A 254 VAL LYS ALA ILE GLU ALA ASN LYS ASN GLY ALA ILE TRP SEQRES 19 A 254 LYS LEU ASP LEU GLY THR LEU GLU ALA ILE GLU TRP THR SEQRES 20 A 254 LYS HIS TRP ASP SER HIS ILE SEQRES 1 B 254 MET ASP LEU THR ASN LYS ASN VAL ILE PHE VAL ALA ALA SEQRES 2 B 254 LEU GLY GLY ILE GLY LEU ASP THR SER ARG GLU LEU VAL SEQRES 3 B 254 LYS ARG ASN LEU LYS ASN PHE VAL ILE LEU ASP ARG VAL SEQRES 4 B 254 GLU ASN PRO THR ALA LEU ALA GLU LEU LYS ALA ILE ASN SEQRES 5 B 254 PRO LYS VAL ASN ILE THR PHE HIS THR TYR ASP VAL THR SEQRES 6 B 254 VAL PRO VAL ALA GLU SER LYS LYS LEU LEU LYS LYS ILE SEQRES 7 B 254 PHE ASP GLN LEU LYS THR VAL ASP ILE LEU ILE ASN GLY SEQRES 8 B 254 ALA GLY ILE LEU ASP ASP HIS GLN ILE GLU ARG THR ILE SEQRES 9 B 254 ALA ILE ASN PHE THR GLY LEU VAL ASN THR THR THR ALA SEQRES 10 B 254 ILE LEU ASP PHE TRP ASP LYS ARG LYS GLY GLY PRO GLY SEQRES 11 B 254 GLY ILE ILE ALA ASN ILE CYS SER VAL THR GLY PHE ASN SEQRES 12 B 254 ALA ILE HIS GLN VAL PRO VAL TYR SER ALA SER LYS ALA SEQRES 13 B 254 ALA VAL VAL SER PHE THR ASN SER LEU ALA LYS LEU ALA SEQRES 14 B 254 PRO ILE THR GLY VAL THR ALA TYR SER ILE ASN PRO GLY SEQRES 15 B 254 ILE THR ARG THR PRO LEU VAL HIS THR PHE ASN SER TRP SEQRES 16 B 254 LEU ASP VAL GLU PRO ARG VAL ALA GLU LEU LEU LEU SER SEQRES 17 B 254 HIS PRO THR GLN THR SER GLU GLN CYS GLY GLN ASN PHE SEQRES 18 B 254 VAL LYS ALA ILE GLU ALA ASN LYS ASN GLY ALA ILE TRP SEQRES 19 B 254 LYS LEU ASP LEU GLY THR LEU GLU ALA ILE GLU TRP THR SEQRES 20 B 254 LYS HIS TRP ASP SER HIS ILE HET NAQ A 600 50 HET NAQ B 500 50 HETNAM NAQ NICOTINAMIDE ADENINE DINUCLEOTIDE 3-PENTANONE ADDUCT FORMUL 3 NAQ 2(C26 H35 N7 O15 P2) FORMUL 5 HOH *485(H2 O) HELIX 1 1 GLY A 16 ARG A 28 1 13 HELIX 2 2 PRO A 42 ILE A 51 1 10 HELIX 3 3 VAL A 68 LEU A 82 1 15 HELIX 4 4 ILE A 100 ASN A 107 1 8 HELIX 5 5 THR A 109 TRP A 122 1 14 HELIX 6 6 LYS A 124 LYS A 126 5 3 HELIX 7 7 VAL A 139 GLY A 141 5 3 HELIX 8 8 HIS A 146 THR A 172 5 27 HELIX 9 9 TRP A 195 ASP A 197 5 3 HELIX 10 10 VAL A 202 SER A 208 1 7 HELIX 11 11 SER A 214 ALA A 227 1 14 HELIX 12 12 GLY B 16 ARG B 28 1 13 HELIX 13 13 PRO B 42 ILE B 51 1 10 HELIX 14 14 VAL B 68 LEU B 82 1 15 HELIX 15 15 ILE B 100 ASN B 107 1 8 HELIX 16 16 THR B 109 TRP B 122 1 14 HELIX 17 17 LYS B 124 LYS B 126 5 3 HELIX 18 18 VAL B 139 GLY B 141 5 3 HELIX 19 19 HIS B 146 THR B 172 5 27 HELIX 20 20 PRO B 187 VAL B 189 5 3 HELIX 21 21 TRP B 195 ASP B 197 5 3 HELIX 22 22 VAL B 202 SER B 208 1 7 HELIX 23 23 SER B 214 ALA B 227 1 14 SHEET 1 A 8 THR A 240 ALA A 243 0 SHEET 2 A 8 ILE A 233 ASP A 237 -1 N ASP A 237 O THR A 240 SHEET 3 A 8 VAL A 174 PRO A 181 1 N SER A 178 O TRP A 234 SHEET 4 A 8 GLY A 131 ILE A 136 1 N GLY A 131 O THR A 175 SHEET 5 A 8 ILE A 87 ASN A 90 1 N LEU A 88 O ILE A 132 SHEET 6 A 8 ASN A 7 VAL A 11 1 N ILE A 9 O ILE A 87 SHEET 7 A 8 ASN A 32 ASP A 37 1 N ASN A 32 O VAL A 8 SHEET 8 A 8 ASN A 56 THR A 61 1 N ASN A 56 O PHE A 33 SHEET 1 B 8 THR B 240 ALA B 243 0 SHEET 2 B 8 ILE B 233 ASP B 237 -1 N ASP B 237 O THR B 240 SHEET 3 B 8 VAL B 174 PRO B 181 1 N SER B 178 O TRP B 234 SHEET 4 B 8 GLY B 131 ILE B 136 1 N GLY B 131 O THR B 175 SHEET 5 B 8 ILE B 87 ASN B 90 1 N LEU B 88 O ILE B 132 SHEET 6 B 8 ASN B 7 VAL B 11 1 N ILE B 9 O ILE B 87 SHEET 7 B 8 ASN B 32 ASP B 37 1 N ASN B 32 O VAL B 8 SHEET 8 B 8 ASN B 56 THR B 61 1 N ASN B 56 O PHE B 33 SITE 1 AC1 3 SER A 138 TYR A 151 LYS A 155 SITE 1 NA1 3 ALA A 13 GLY A 15 GLY A 18 SITE 1 NA2 3 ALA A 12 GLY A 16 GLY A 18 SITE 1 NA3 1 ASP A 37 SITE 1 AC2 3 SER B 138 TYR B 151 LYS B 155 SITE 1 NA4 3 ALA B 13 GLY B 15 GLY B 18 SITE 1 NA5 3 ALA B 12 GLY B 16 GLY B 18 SITE 1 NA6 1 ASP B 37 SITE 1 AC3 31 ALA A 12 GLY A 15 GLY A 16 ILE A 17 SITE 2 AC3 31 ASP A 37 TYR A 62 ASP A 63 VAL A 64 SITE 3 AC3 31 GLY A 91 ALA A 92 GLY A 93 ILE A 106 SITE 4 AC3 31 ILE A 136 CYS A 137 SER A 138 VAL A 139 SITE 5 AC3 31 ILE A 145 TYR A 151 LYS A 155 PRO A 181 SITE 6 AC3 31 GLY A 182 ILE A 183 THR A 184 THR A 186 SITE 7 AC3 31 LEU A 188 HOH A 633 HOH A 641 HOH A 659 SITE 8 AC3 31 HOH A 724 HOH A 745 HOH A 850 SITE 1 AC4 31 ALA B 12 GLY B 15 GLY B 16 ILE B 17 SITE 2 AC4 31 ASP B 37 ARG B 38 TYR B 62 ASP B 63 SITE 3 AC4 31 VAL B 64 GLY B 91 ALA B 92 GLY B 93 SITE 4 AC4 31 ILE B 106 ILE B 136 CYS B 137 SER B 138 SITE 5 AC4 31 VAL B 139 ILE B 145 TYR B 151 LYS B 155 SITE 6 AC4 31 PRO B 181 GLY B 182 ILE B 183 THR B 184 SITE 7 AC4 31 THR B 186 LEU B 188 HOH B 538 HOH B 553 SITE 8 AC4 31 HOH B 649 HOH B 689 HOH B 696 CRYST1 66.800 53.000 70.500 90.00 107.20 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014970 0.000000 0.004634 0.00000 SCALE2 0.000000 0.018868 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014848 0.00000 MTRIX1 1 -0.983274 -0.169734 0.066045 23.22419 1 MTRIX2 1 -0.169547 0.720587 -0.672316 12.31010 1 MTRIX3 1 0.066524 -0.672268 -0.737312 25.47263 1 MASTER 331 0 2 23 16 0 24 9 0 0 0 40 END